LATEST NEWS
TRENDING NEWS
- Cancer Researchers Receive Grant to Study Indolent Neuroblastoma
- CalAmp Unveils Proven End-To-End Supply Chain Visibility Solution for Refrigerated Vaccines, Pharmaceuticals and Other High-Value Shipments
- Hoth Therapeutics Announces its mRNA Frame Shifting Therapeutic Significantly Inhibits Tumor Growth in Mast Cell-Derived Cancers
- Valneva Switches Focus to Bilateral Discussions to Supply its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
- Apic Bio Announces FDA Clearance of IND Application for Lead Gene Therapy Candidate APB-102 for the Treatment of SOD1 ALS
- Prestige Biopharma’s New Vaccine Production Centre for Infectious Diseases Including COVID-19
- 3 International Cancer Researchers to Receive the 2021 Fondation ARC Léopold Griffuel Prize
- Steba Biotech Treats First Patient in Pivotal ENLIGHTED Study of Padeliporfin ImPACT in Low Grade Upper Tract Urothelial Cancer
- Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
- Autolus Therapeutics Receives Innovation Passport and entry into ILAP for AUTO4 for the treatment of T cell receptor constant region beta chain 1 (TRBC1) positive T cell lymphomas
